Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

We have a patient on EURAMOS 1 who should be having surgery this week but not sure if this is going to go ahead. Should we be giving additional methotrexate if surgery is delayed?

0
Posted

We have a patient on EURAMOS 1 who should be having surgery this week but not sure if this is going to go ahead. Should we be giving additional methotrexate if surgery is delayed?

0

Patients should have no more than six courses of methotrexate (MTX) administered before surgery to be eligible for randomization. If the patient has already had 4 courses of MTX (i.e. in cycle 1 and 2) then another 2 courses of MTX could be given before surgery. If given, this additional MTX should be recorded on the Chemotherapy form for cycle 2 (questions 14-16 should be answered).

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.